Tracy A. Lieu, MD, MPH

A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.

When preventive care was exempt from the deductible, well-child visits did not change for children switching from traditional plans to high-deductible plans.